Answer
Lemtrada (alemtuzumab) should be administered during pregnancy only if the potential benefit justifies the potential risk to the foetus, with only limited data available on use in pregnant women.
Sources for this answer
- LEMTRADA 12 mg concentrate for solution for infusionSANOFI · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 3Document updated
Sources checked